{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:36:50Z","timestamp":1777390610025,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Clinical Medical Research Special Project of Zhejiang Medical Association","award":["2024ZYC-A343"],"award-info":[{"award-number":["2024ZYC-A343"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Oxidative stress is a key driver of mucosal damage in ulcerative colitis (UC). Antioxidant supplementation may restore redox balance, but its clinical efficacy remains controversial. To evaluate the effects of natural antioxidant substances supplementation on oxidation\/antioxidant biomarkers and clinical outcomes in UC patients. The databases included PubMed, Embase, Web of Science, and Cochrane Library (up to July 2025) were searched, and RCTs comparing oral antioxidants with placebo in UC were included. The primary outcomes were changes in oxidative stress markers (MDA, SOD, TAC, GPX). The secondary outcomes included the short IBD questionnaire (SIBDQ) score and the simple clinical colitis activity index (SCCAI) score. 9 articles involving 624 patients were included in this study. Compared to placebo group, antioxidant substances supplementation could significantly reduce the level of MDA (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.001, SMD=-1.09, 95% CI \u22121.75 to \u22120.43), increased the levels of SOD, TAC, GPX in patients with UC (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.02, SMD\u2009=\u20090.57, 95% CI  0.10 to 1.04;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.0004, SMD\u2009=\u20090.74, 95% CI\u2009 \u20090.33 to 1.16;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.004, SMD\u2009=\u20090.69, 95% CI\u2009 0.22 to 1.16). In addition, antioxidant substances supplementation remarkably decreased the SCCAI score of UC patients (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.04, SMD=-0.62, 95% CI \u22121.21 to \u22120.04), thus improving the disease activity. However, there is no significant difference in the change of IBDQ score (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.13, SMD\u2009=\u20090.55, 95% CI \u22120.17 to 1.28). Natural antioxidant substances supplementation effectively enhanced antioxidant capacity and ameliorated oxidation status, improved the disease activity of UC patients, but had no significant impact on their quality of life. This study will provide a basis for the selection of adjuvant therapy drugs for UC.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-30617-x","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T18:47:18Z","timestamp":1764355638000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Natural antioxidant substances improve oxidative stress and alleviate ulcerative colitis: a meta-analysis of randomized controlled trials"],"prefix":"10.1038","volume":"15","author":[{"given":"Shuo","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"issue":"10","key":"30617_CR1","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.tips.2024.08.003","volume":"45","author":"P Wangchuk","year":"2024","unstructured":"Wangchuk, P., Yeshi, K. & Loukas, A. Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments. Trends Pharmacol. Sci. 45 (10), 892\u2013903 (2024).","journal-title":"Trends Pharmacol. Sci."},{"issue":"10","key":"30617_CR2","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1136\/gutjnl-2024-332489","volume":"73","author":"S Honap","year":"2024","unstructured":"Honap, S. et al. Acute severe ulcerative colitis trials: the past, the present and the future. Gut 73 (10), 1763\u20131773 (2024).","journal-title":"Gut"},{"issue":"6","key":"30617_CR3","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.14309\/ajg.0000000000003463","volume":"120","author":"DT Rubin","year":"2025","unstructured":"Rubin, D. T. et al. ACG clinical guideline update: ulcerative colitis in Adults. Am. J. Gastroenterol. 120 (6), 1187\u20131224 (2025).","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"30617_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/1744666X.2023.2292768","volume":"20","author":"F D\u2019Amico","year":"2024","unstructured":"D\u2019Amico, F. et al. Management and treatment optimization of patients with mild to moderate ulcerative colitis. Expert Rev. Clin. Immunol. 20 (3), 277\u2013290 (2024).","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"3","key":"30617_CR5","first-page":"129","volume":"117","author":"R Li","year":"2025","unstructured":"Li, R. & Yang, L. Research progress in the combined treatment of ulcerative colitis. Rev. Esp. Enferm Dig. 117 (3), 129\u2013135 (2025).","journal-title":"Rev. Esp. Enferm Dig."},{"issue":"4","key":"30617_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/MOG.0000000000001023","volume":"40","author":"T Nagaraj","year":"2024","unstructured":"Nagaraj, T., Shinn, J. & De Felice, K. A practical guide to selecting and using new ulcerative colitis therapies. Curr. Opin. Gastroenterol. 40 (4), 235\u2013242 (2024).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"30617_CR7","doi-asserted-by":"publisher","first-page":"103380","DOI":"10.1016\/j.redox.2024.103380","volume":"77","author":"A Tratensek","year":"2024","unstructured":"Tratensek, A. et al. Oxidative stress-related biomarkers as promising indicators of inflammatory bowel disease activity: A systematic review and meta-analysis. Redox Biol. 77, 103380 (2024).","journal-title":"Redox Biol."},{"key":"30617_CR8","doi-asserted-by":"publisher","first-page":"1328324","DOI":"10.3389\/fmicb.2024.1328324","volume":"15","author":"Y Sun","year":"2024","unstructured":"Sun, Y. et al. The role of gut microbiota in intestinal disease: from an oxidative stress perspective. Front. Microbiol. 15, 1328324 (2024).","journal-title":"Front. Microbiol."},{"key":"30617_CR9","doi-asserted-by":"publisher","first-page":"1390351","DOI":"10.3389\/fendo.2024.1390351","volume":"15","author":"P Muro","year":"2024","unstructured":"Muro, P. et al. The emerging role of oxidative stress in inflammatory bowel disease. Front. Endocrinol. (Lausanne). 15, 1390351 (2024).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"30617_CR10","doi-asserted-by":"publisher","first-page":"1217165","DOI":"10.3389\/fendo.2023.1217165","volume":"14","author":"DK Sahoo","year":"2023","unstructured":"Sahoo, D. K. et al. Oxidative stress, hormones, and effects of natural antioxidants on intestinal inflammation in inflammatory bowel disease. Front. Endocrinol. (Lausanne). 14, 1217165 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"23","key":"30617_CR11","doi-asserted-by":"publisher","first-page":"17124","DOI":"10.3390\/ijms242317124","volume":"24","author":"MJ Sanchez-Quintero","year":"2023","unstructured":"Sanchez-Quintero, M. J. et al. Role of mitochondria in inflammatory bowel diseases: A systematic Review. Int. J. Mol. Sci. 24 (23), 17124 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"30617_CR12","doi-asserted-by":"publisher","first-page":"5438","DOI":"10.1021\/acs.jafc.3c00798","volume":"71","author":"Z Tang","year":"2023","unstructured":"Tang, Z. et al. Heat stress-Induced intestinal barrier impairment: current insights into the aspects of oxidative stress and Endoplasmic reticulum stress. J. Agric. Food Chem. 71 (14), 5438\u20135449 (2023).","journal-title":"J. Agric. Food Chem."},{"issue":"3","key":"30617_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/17474124.2022.2048817","volume":"16","author":"H Wang","year":"2022","unstructured":"Wang, H. et al. Role of vitamin D in ulcerative colitis: an update on basic research and therapeutic applications. Expert Rev. Gastroenterol. Hepatol. 16 (3), 251\u2013264 (2022).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"30617_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12937-019-0441-7","volume":"18","author":"S Karimi","year":"2019","unstructured":"Karimi, S. et al. The effects of two vitamin D regimens on ulcerative colitis activity index, quality of life and oxidant\/anti-oxidant status. Nutr. J. 18 (1), 16 (2019).","journal-title":"Nutr. J."},{"issue":"22","key":"30617_CR15","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.3390\/molecules24224132","volume":"24","author":"SC Lourenco","year":"2019","unstructured":"Lourenco, S. C., Moldao-Martins, M. & Alves, V. D. Antioxidants of natural plant origins: from sources to food industry Applications. Molecules 24 (22), 4132 (2019).","journal-title":"Molecules"},{"issue":"6","key":"30617_CR16","doi-asserted-by":"publisher","first-page":"6579","DOI":"10.1007\/s00210-025-03811-x","volume":"398","author":"T Gangwar","year":"2025","unstructured":"Gangwar, T. et al. Therapeutic potential and underlying mechanisms of phytoconstituents: emphasizing on resveratol, curcumin, quercetin, berberine, and hesperidin in ulcerative colitis. Naunyn Schmiedebergs Arch. Pharmacol. 398 (6), 6579\u20136596 (2025).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"7","key":"30617_CR17","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/1061186X.2025.2469750","volume":"33","author":"Y Garg","year":"2025","unstructured":"Garg, Y. et al. Resveratrol in ulcerative colitis: therapeutic mechanisms, animal model evidence and novel approaches. J. Drug Target. 33 (7), 1043\u20131066 (2025).","journal-title":"J. Drug Target."},{"issue":"10","key":"30617_CR18","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.3390\/nu16101504","volume":"16","author":"O Erol Dogan","year":"2024","unstructured":"Erol Dogan, O. et al. Effects of mediterranean Diet, Curcumin, and Resveratrol on Mild-to-Moderate active ulcerative colitis: A multicenter randomized clinical Trial. Nutrients 16 (10), 1504 (2024).","journal-title":"Nutrients"},{"issue":"8","key":"30617_CR19","doi-asserted-by":"publisher","first-page":"4390","DOI":"10.3390\/ijms25084390","volume":"25","author":"S Jarmakiewicz-Czaja","year":"2024","unstructured":"Jarmakiewicz-Czaja, S. et al. Nutritional support: the use of antioxidants in inflammatory bowel Disease. Int. J. Mol. Sci. 25 (8), 4390 (2024).","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"30617_CR20","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1007\/s00394-021-02514-2","volume":"60","author":"F Farsi","year":"2021","unstructured":"Farsi, F. et al. A randomized controlled trial on the coloprotective effect of coenzyme Q10 on immune-inflammatory cytokines, oxidative status, antimicrobial peptides, and microRNA-146a expression in patients with mild-to-moderate ulcerative colitis. Eur. J. Nutr. 60 (6), 3397\u20133410 (2021).","journal-title":"Eur. J. Nutr."},{"issue":"8","key":"30617_CR21","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1007\/s00394-023-03214-9","volume":"62","author":"M Khazdouz","year":"2023","unstructured":"Khazdouz, M. et al. The effect of selenium supplementation on disease activity and immune-inflammatory biomarkers in patients with mild-to-moderate ulcerative colitis: a randomized, double-blind, placebo-controlled clinical trial. Eur. J. Nutr. 62 (8), 3125\u20133134 (2023).","journal-title":"Eur. J. Nutr."},{"key":"30617_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctim.2018.12.021","volume":"43","author":"M Nikkhah-Bodaghi","year":"2019","unstructured":"Nikkhah-Bodaghi, M. et al. Zingiber officinale and oxidative stress in patients with ulcerative colitis: A randomized, placebo-controlled, clinical trial. Complement. Ther. Med. 43, 1\u20136 (2019).","journal-title":"Complement. Ther. Med."},{"issue":"4","key":"30617_CR23","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/ptr.6296","volume":"33","author":"M Nikkhah-Bodaghi","year":"2019","unstructured":"Nikkhah-Bodaghi, M. et al. The effects of Nigella sativa on quality of life, disease activity index, and some of inflammatory and oxidative stress factors in patients with ulcerative colitis. Phytother Res. 33 (4), 1027\u20131032 (2019).","journal-title":"Phytother Res."},{"issue":"1","key":"30617_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12906-024-04400-w","volume":"24","author":"S Moradi","year":"2024","unstructured":"Moradi, S. et al. Effects of spirulina supplementation in patients with ulcerative colitis: a double-blind, placebo-controlled randomized trial. BMC Complement. Med. Ther. 24 (1), 109 (2024).","journal-title":"BMC Complement. Med. Ther."},{"issue":"4","key":"30617_CR25","doi-asserted-by":"publisher","first-page":"103170","DOI":"10.1016\/j.explore.2025.103170","volume":"21","author":"M Morvaridi","year":"2025","unstructured":"Morvaridi, M. et al. The impact of Zataria multiflora on oxidative stress biomarkers and ulcerative colitis symptoms: A multicenter, triple-blind, placebo-controlled clinical trial. Explore (NY). 21 (4), 103170 (2025).","journal-title":"Explore (NY)"},{"key":"30617_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.hermed.2017.05.002","volume":"9","author":"S Shiva Nematgorgani","year":"2017","unstructured":"Shiva Nematgorgani, S. et al. Effects of urtica dioica leaf extract on inflammation, oxidative stress, ESR, blood cell count and quality of life in patients with inflammatory bowel disease. J. Herb. Med. 9, 32\u201341 (2017).","journal-title":"J. Herb. Med."},{"issue":"4","key":"30617_CR27","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.arcmed.2016.07.003","volume":"47","author":"M Samsamikor","year":"2016","unstructured":"Samsamikor, M. et al. Resveratrol supplementation and Oxidative\/Anti-Oxidative status in patients with ulcerative colitis: A Randomized, Double-Blind, Placebo-controlled pilot Study. Arch. Med. Res. 47 (4), 304\u2013309 (2016).","journal-title":"Arch. Med. Res."},{"issue":"2","key":"30617_CR28","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/ptr.6848","volume":"35","author":"N Tahvilian","year":"2021","unstructured":"Tahvilian, N. et al. Effects of saffron supplementation on oxidative\/antioxidant status and severity of disease in ulcerative colitis patients: A randomized, double-blind, placebo-controlled study. Phytother Res. 35 (2), 946\u2013953 (2021).","journal-title":"Phytother Res."},{"key":"30617_CR29","doi-asserted-by":"crossref","unstructured":"Wang, Z. et al. Oxidative stress and carbonyl lesions in ulcerative colitis and associated colorectal cancer. Oxid. Med. Cell Longev. 2016, 9875298. (2016).","DOI":"10.1155\/2016\/9875298"},{"issue":"1","key":"30617_CR30","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1038\/s41467-023-39173-2","volume":"14","author":"J Du","year":"2023","unstructured":"Du, J. et al. Selective oxidative protection leads to tissue topological changes orchestrated by macrophage during ulcerative colitis. Nat. Commun. 14 (1), 3675 (2023).","journal-title":"Nat. Commun."},{"issue":"4","key":"30617_CR31","doi-asserted-by":"publisher","first-page":"C849","DOI":"10.1152\/ajpcell.00283.2008","volume":"295","author":"DP Jones","year":"2008","unstructured":"Jones, D. P. Radical-free biology of oxidative stress. Am. J. Physiol. Cell. Physiol. 295 (4), C849\u2013868 (2008).","journal-title":"Am. J. Physiol. Cell. Physiol."},{"issue":"1","key":"30617_CR32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41392-024-02095-6","volume":"10","author":"B Li","year":"2025","unstructured":"Li, B. et al. Redox regulation: mechanisms, biology and therapeutic targets in diseases. Signal. Transduct. Target. Ther. 10 (1), 72 (2025).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"3","key":"30617_CR33","doi-asserted-by":"publisher","first-page":"e13145","DOI":"10.1111\/jfbc.13145","volume":"44","author":"SS Ali","year":"2020","unstructured":"Ali, S. S. et al. Understanding oxidants and antioxidants: classical team with new players. J. Food Biochem. 44 (3), e13145 (2020).","journal-title":"J. Food Biochem."},{"key":"30617_CR34","doi-asserted-by":"publisher","first-page":"111865","DOI":"10.1016\/j.intimp.2024.111865","volume":"131","author":"X Ding","year":"2024","unstructured":"Ding, X. et al. Integration of transcriptomics and metabolomics identify biomarkers of aberrant lipid metabolism in ulcerative colitis. Int. Immunopharmacol. 131, 111865 (2024).","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"30617_CR35","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13020-023-00819-4","volume":"18","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Gegen Qinlian Decoction (GQD) inhibits ulcerative colitis by modulating ferroptosis-dependent pathway in mice and organoids. Chin. Med. 18 (1), 110 (2023).","journal-title":"Chin. Med."},{"key":"30617_CR36","doi-asserted-by":"publisher","first-page":"121596","DOI":"10.1016\/j.lfs.2023.121596","volume":"321","author":"M Shalaby","year":"2023","unstructured":"Shalaby, M. et al. Imatinib mitigates experimentally-induced ulcerative colitis: possible contribution of NF-kB\/JAK2\/STAT3\/COX2 signaling pathway. Life Sci. 321, 121596 (2023).","journal-title":"Life Sci."},{"issue":"5","key":"30617_CR37","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/ueg2.12585","volume":"12","author":"I Marafini","year":"2024","unstructured":"Marafini, I., Roseira, J. & Duijvestein, M. Treatment options for refractory ulcerative colitis: small molecules, big effects. United Eur. Gastroenterol. J. 12 (5), 539\u2013540 (2024).","journal-title":"United Eur. Gastroenterol. J."},{"issue":"11","key":"30617_CR38","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1093\/ibd\/izad282","volume":"30","author":"M Dubinsky","year":"2024","unstructured":"Dubinsky, M. et al. Systematic literature review: ability of the IBDQ-32 to detect meaningful change in ulcerative colitis health Indicators. Inflamm. Bowel Dis. 30 (11), 2115\u20132126 (2024).","journal-title":"Inflamm. Bowel Dis."},{"key":"30617_CR39","doi-asserted-by":"publisher","first-page":"650971","DOI":"10.3389\/fnins.2021.650971","volume":"15","author":"B Bonaz","year":"2021","unstructured":"Bonaz, B., Sinniger, V. & Pellissier, S. Therapeutic potential of vagus nerve stimulation for inflammatory bowel Diseases. Front. Neurosci. 15, 650971 (2021).","journal-title":"Front. Neurosci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30617-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30617-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30617-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T15:30:18Z","timestamp":1777131018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30617-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["30617"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-30617-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"31 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45636"}}